FindTrial
Sign In

Comparison of diode laser (980nm) enucleation versus holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia: a prospective and randomized clinical trial

Comparison of diode laser (980nm) enucleation versus holmium laser enucleation of the prostate for the treatment of benign prostatic hyperplasia: a prospective and randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022075
Enrollment
Unknown
Registered
2019-03-23
Start date
2019-06-01
Completion date
Unknown
Last updated
2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostate Hyperplasia

Interventions

DiLEP group:receive DiLEP surgery
HoLEP group:receive HoLEP surgery

Sponsors

The Second Affiliated Hospital, School of Medicine, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) prostate volume (PV)=30mL; (2) maximum flow rate (Qmax)=15 mL/s; (3) quality of life (QoL) score=3; (4) international prostate symptom score (IPSS)=8.

Exclusion criteria

Exclusion criteria: (1) confirmed prostate cancer or history of prostate surgery; (2) acute prostatitis or urethritis; (3) neurogenic bladder and urethral injury.

Design outcomes

Primary

MeasureTime frame
international prostate symptoms score(IPSS);postvoid residual (PVR);maximum urinary flow rate (Qmax);quality of life score (QoL);—

Countries

China

Contacts

Public ContactJiaming Wen

The Second Affiliated Hospital, School of Medicine, Zhejiang University

wenjiaming@zju.edu.cn+86 13989810142

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026